Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon`s, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as...
Website: angiodynamics.com



Growth: Good revenue growth rate 17.9%, there is acceleration compared to average historical growth rates -0.7%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -4.5%. On average the margin is decreasing steadily. Gross margin is high, +53.1%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 50% of quarters (showing a gain of -$0.01 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -1.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 96.0% higher than minimum and 24.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.5x by EV / Sales multiple , the company can be 14.2% undervalued

Key Financials (Download financials)

Ticker: ANGO
Share price, USD:  (0.0%)10.33
year average price 10.52  


year start price 10.34 2025-02-14

min close price 8.37 2025-03-10

max close price 13.64 2025-12-22

current price 10.33 2026-02-13
Common stocks: 41 404 000

Dividend Yield:  0.0%
EV / Sales: 1.3x
Margin (EBITDA LTM / Revenue): -4.5%
Fundamental value created in LTM:
Market Cap ($m): 428
Net Debt ($m): -42
EV (Enterprise Value): 386
Price to Book: 2.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-30zacks.com

Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now

2026-01-29zacks.com

Reasons to Add AngioDynamics Stock to Your Portfolio for Now

2026-01-14seekingalpha.com

AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-13zacks.com

3 MedTech Stocks Benefiting From Favorable Product Mix Shifts

2025-12-29seekingalpha.com

AngioDynamics: Growth Remains Under The Radar

2025-12-24zacks.com

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

2025-11-21zacks.com

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

2025-10-02seekingalpha.com

AngioDynamics: Discounted Sales Multiple With Real Growth Engines

2025-10-02seekingalpha.com

AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript

2025-10-02zacks.com

AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q4 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q2 2021 q2
date 2025-11-30 2025-08-31 2025-05-31 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-05-31 2023-02-28 2022-11-30 2022-05-31 2021-05-31
symbol ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2026-01-06 2025-10-02 2024-10-03 2024-04-09 2024-01-08 2023-10-05 2023-03-31 2023-01-06
acceptedDate 2026-01-06 15:19:18 2025-10-02 16:07:51 2025-07-18 10:38:14 2024-10-03 17:08:17 2024-07-25 16:13:50 2024-04-09 17:08:59 2024-01-08 16:47:30 2023-10-05 17:15:12 2023-08-03 17:16:14 2023-03-31 14:32:28 2023-01-06 16:55:55 2022-07-22 15:01:59 2021-07-27 13:54:28
calendarYear 2026 2026 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 79M 76M 292M 67M 304M 75M 79M 79M 339M 81M 85M 316M 291M
costOfRevenue 37M 34M 135M 31M 149M 43M 39M 39M 165M 40M 40M 150M 134M
grossProfit 42M 42M 158M 37M 155M 33M 40M 40M 174M 41M 45M 166M 157M
grossProfitRatio 0.531 0.553 0.544 0.433 0.509 0.509 0.502 0.528
researchAndDevelopmentExpenses 8M 6M 26M 6M 32M 8M 9M 8M 30M 7M 7M 31M 36M
generalAndAdministrativeExpenses 10M 13M 42M 11M 41M 11M 9M 11M 40M 9M 11M 38M 36M
sellingAndMarketingExpenses 27M 28M 103M 26M 103M 25M 25M 27M 104M 25M 26M 95M 81M
sellingGeneralAndAdministrativeExpenses 37M 41M 145M 37M 144M 36M 35M 38M 144M 34M 37M 134M 117M
otherExpenses 0 5M 26M 7M 172M -238 000 -32 000 -288 000 51M 5M 5M 30M 38M
operatingExpenses 45M 53M 198M 50M 347M 44M 47M 50M 225M 46M 48M 194M 192M
costAndExpenses 82M 86M 332M 81M 496M 87M 86M 88M 390M 86M 89M 345M 326M
interestIncome 0 0 978 000 606 000 2M 0 534 000 119 000 0 0 0 0 0
interestExpense 102 000 4000 0 0 0 394 000 534 000 119 000 3M 736 000 684 000 688 000 861 000
depreciationAndAmortization 6M 6M 26M 7M 28M 8M 7M 7M 31M 8M 8M 29M 26M
ebitda -436 000 -5M 2M -2M -6M -4M 6M -48M 12M 3M 4M 11M -9M
ebitdaratio -0.005 -0.064 -0.029 -0.054 0.081 -0.608 0.031 0.049
operatingIncome -2M -11M -40M -13M -192M -12M -13M 35M -51M -5M -4M -28M -35M
operatingIncomeRatio -0.031 -0.141 -0.194 -0.154 -0.166 0.445 -0.066 -0.043
totalOtherIncomeExpensesNet -4M -182 000 6M 433 000 797 000 -188M -6M 44M -3M -4M -5M -1M -769 000
incomeBeforeTax -6M -11M -34M -13M -192M -200M -13M 35M -54M -10M -9M -30M -36M
incomeBeforeTaxRatio -0.08 -0.143 -0.188 -2.657 -0.16 0.443 -0.12 -0.106
incomeTaxExpense -5000 65 000 -39 000 133 000 -7M -12M 16M -11M -2M -179 000 -565 000 -3M -5M
netIncome -6M -11M -34M -13M -184M -188M -29M 46M -52M -9M -8M -27M -32M
netIncomeRatio -0.08 -0.144 -0.19 -2.497 -0.367 0.583 -0.118 -0.099
eps -0.15 -0.26 -0.83 -0.31 -4.59 -4.67 -0.72 1.15 -1.33 -0.24 -0.21 -0.68 -0.82
epsdiluted -0.15 -0.26 -0.31 -4.67 -0.72 1.15 -0.24 -0.21
weightedAverageShsOut 41M 41M 41M 41M 40M 40M 40M 40M 39M 40M 39M 39M 38M
weightedAverageShsOutDil 41M 41M 41M 41M 40M 40M 40M 40M 39M 40M 39M 39M 38M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-07-18 2024-07-25 2023-08-03 2022-07-22 2021-07-27
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome 978 000 2M -3M -688 000 -861 000
ebit -24M -34M -19M -18M -35M
nonOperatingIncomeExcludingInterest -16M -159M -33M -10M -92 000
netIncomeFromContinuingOperations -34M -184M -52M -27M -32M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -34M -184M -52M -27M -32M
epsDiluted -0.83 -4.59 -1.33 -0.68 -0.82

Balance Sheet Statement

Property 2025 q4 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q2 2021 q2
date 2025-11-30 2025-08-31 2025-05-31 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-05-31 2023-02-28 2022-11-30 2022-05-31 2021-05-31
symbol ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2026-01-06 2025-10-02 2024-10-03 2024-04-09 2024-01-08 2023-10-05 2023-03-31 2023-01-06
acceptedDate 2026-01-06 15:19:18 2025-10-02 16:07:51 2025-07-18 10:38:14 2024-10-03 17:08:17 2024-07-25 16:13:50 2024-04-09 17:08:59 2024-01-08 16:47:30 2023-10-05 17:15:12 2023-08-03 17:16:14 2023-03-31 14:32:28 2023-01-06 16:55:55 2022-07-22 15:01:59 2021-07-27 13:54:28
calendarYear 2026 2026 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 42M 39M 56M 55M 76M 78M 61M 58M 45M 30M 30M 29M 48M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 42M 39M 56M 55M 76M 78M 61M 58M 45M 30M 30M 29M 48M
netReceivables 44M 43M 43M 40M 50M 49M 52M 50M 53M 51M 53M 56M 37M
inventory 66M 62M 62M 65M 61M 58M 64M 60M 55M 64M 63M 51M 49M
otherCurrentAssets 10M 13M 3M 13M 3M 11M 9M 8M 7M 8M 13M 2M 2M
totalCurrentAssets 161M 157M 168M 173M 193M 197M 185M 175M 164M 153M 159M 143M 141M
propertyPlantEquipmentNet 31M 31M 32M 34M 36M 41M 43M 43M 44M 46M 46M 45M 37M
goodwill 0 0 0 0 0 0 159M 159M 159M 200M 201M 201M 201M
intangibleAssets 67M 68M 69M 76M 77M 82M 104M 107M 111M 134M 142M 152M 169M
goodwillAndIntangibleAssets 67M 68M 69M 76M 77M 82M 263M 266M 270M 334M 343M 353M 370M
longTermInvestments 0 0 0 -5M 0 -6M -18M -1M 0 0 0 0 0
taxAssets 0 0 0 5M 0 6M 18M 1M 0 13M 14M 0 0
otherNonCurrentAssets 11M 10M 10M 6M 11M 5M 8M 9M 54M -3M -4M 11M 13M
totalNonCurrentAssets 108M 109M 112M 121M 124M 128M 314M 318M 369M 390M 399M 409M 421M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0
totalAssets 270M 266M 280M 294M 318M 325M 500M 494M 533M 543M 558M 553M 561M
accountPayables 35M 32M 33M 31M 38M 35M 38M 25M 40M 36M 35M 28M 20M
shortTermDebt 0 0 0 2M 5M 2M 2M 5M 15M 10M 0 9M 0
taxPayables 0 0 0 894 000 520 000 508 000 608 000 2M 480 000 328 000 815 000 750 000 631 000
deferredRevenue 0 0 0 0 0 0 -2M 26M 0 13M 14M 0 0
otherCurrentLiabilities 37M 36M 9M 43M 9M 49M 40M 2M 2M 11M 25M 3M 3M
totalCurrentLiabilities 72M 68M 76M 77M 91M 86M 78M 57M 84M 70M 74M 74M 58M
longTermDebt 0 0 0 3M 0 2M 3M 0 50M 50M 50M 25M 20M
deferredRevenueNonCurrent 0 0 0 0 0 -2M -3M 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 4M 4M 4M 5M 5M 6M 18M 1M 13M 13M 14M 16M 20M
otherNonCurrentLiabilities 17M 14M 17M 12M 16M 14M 3M 7M 8M 12M 13M 13M 24M
totalNonCurrentLiabilities 21M 19M 21M 20M 21M 20M 20M 9M 71M 76M 77M 54M 64M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 0 5M 0 2M 3M 3M 0 0 0 0 0
totalLiabilities 93M 87M 97M 97M 112M 106M 98M 66M 154M 145M 150M 128M 122M
preferredStock 0 0 0 0 0 384M 198M 170M 0 0 0 0 0
commonStock 386 000 386 000 385 000 386 000 385 000 385 000 383 000 383 000 382 000 382 000 381 000 380 000 377 000
retainedEarnings -446M -440M -429M -408M -395M -382M -194M -165M -211M -189M -180M -158M -132M
accumulatedOtherComprehensiveIncomeLoss 998 000 61 000 -2M -3M -4M -3M -5M -6M -5M -4M -288 000 1M 3M
othertotalStockholdersEquity 621M 619M 607M 219M 401M 428M 591M 588M
totalStockholdersEquity 176M 179M 183M 197M 206M 219M 401M 428M 378M 398M 408M 424M 439M
totalEquity 176M 179M 183M 197M 206M 219M 401M 428M 378M 398M 408M 424M 439M
totalLiabilitiesAndStockholdersEquity 270M 266M 294M 325M 500M 494M 543M 558M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 270M 266M 280M 294M 318M 325M 500M 494M 533M 543M 558M 553M 561M
totalInvestments 0 0 0 -5M 0 -6M -18M -1M 0 0 0 0 0
totalDebt 0 0 0 5M 5M 4M 4M 5M 65M 60M 50M 34M 20M
netDebt -42M -39M -56M -50M -71M -74M -57M -53M 20M 30M 20M 5M -28M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-07-18 2024-07-25 2023-08-03 2022-07-22 2021-07-27
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 43M 44M 53M 52M 35M
otherReceivables 250 000 6M 0 4M 2M
prepaids 4M 4M 4M 4M 5M
totalPayables 36M 45M 41M 29M 20M
otherPayables 3M 7M 480 000 750 000 631 000
accruedExpenses 32M 33M 26M 34M 34M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 0 0 0 0 0
treasuryStock -7M -6M -6M -6M -6M
additionalPaidInCapital 621M 610M 599M 587M 574M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q4 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q2 2021 q2
date 2025-11-30 2025-08-31 2025-05-31 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-05-31 2023-02-28 2022-11-30 2022-05-31 2021-05-31
symbol ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO ANGO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2026-01-06 2025-10-02 2024-10-03 2024-04-09 2024-01-08 2023-10-05 2023-03-31 2023-01-06
acceptedDate 2026-01-06 15:19:18 2025-10-02 16:07:51 2025-07-18 10:38:14 2024-10-03 17:08:17 2024-07-25 16:13:50 2024-04-09 17:08:59 2024-01-08 16:47:30 2023-10-05 17:15:12 2023-08-03 17:16:14 2023-03-31 14:32:28 2023-01-06 16:55:55 2022-07-22 15:01:59 2021-07-27 13:54:28
calendarYear 2026 2026 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome -6M -11M -34M -13M -184M -188M -29M 46M -52M -9M -8M -27M -32M
depreciationAndAmortization 6M 6M 26M 7M 28M 8M 7M 7M 31M 8M 8M 29M 26M
deferredIncomeTax -48 000 -16 000 -988 000 -339 000 -8M -12M 16M -11M -2M -227 000 -618 000 -4M -5M
stockBasedCompensation 3M 4M 10M 3M 11M 3M 2M 4M 11M 2M 3M 11M 9M
changeInWorkingCapital 2M -16M -14M -16M 14M 19M 8M -22M -7M 628 000 3M -21M 9M
accountsReceivables -2M 139 000 23 000 4M 8M 2M -2M 3M -1M 2M 406 000 -17M -4M
inventory -3M -192 000 -1M -4M -9M 2M -4M -5M -8M -423 000 -6M -3M 12M
accountsPayables 3M -11M -16M -15M 28M 18M 16M -17M 2M -4M 6M 4M 5M
otherWorkingCapital 3M -6M 3M -836 000 -12M -3M -811 000 -4M 332 000 4M 2M -5M -3M
otherNonCashItems 790 000 790 000 3M 981 000 111M 158M 1M -49M 20M 813 000 3M 4M 17M
netCashProvidedByOperatingActivities 5M -16M -10M -18M -28M -13M 5M -26M 78 000 1M 7M -7M 24M
investmentsInPropertyPlantAndEquipment -422 000 -731 000 -4M -1M -3M -4M -554 000 -791 000 -4M -666 000 -1M -4M -5M
acquisitionsNet 0 0 0 0 0 35M 0 100M 0 0 0 -4M 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites -1M -820 000 -1M -1M -1M -767 000 -1M -1M
netCashUsedForInvestingActivites -2M -2M -2M 29M -2M 98M -2M -2M
debtRepayment 0 -91 000 0 0 0 -50M -45M 0
commonStockIssued 0 234 000 0 694 000 -352 000 410 000 941 000 148 000
commonStockRepurchased 0 0 -2M -552 000 0 0 -352 000 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0
otherFinancingActivites -92 000 0 43 000 694 000 0 -10M 45M -45 000
netCashUsedProvidedByFinancingActivities -92 000 143 000 -509 000 694 000 -352 000 -60M 941 000 103 000
effectOfForexChangesOnCash -72 000 191 000 398 000 116 000 125 000 -17 000 189 000 13 000 43 000 89 000 187 000 -518 000 330 000
netChangeInCash 3M -17M -20M -21M 31M 18M 3M 13M 16M 254 000 5M -19M -6M
cashAtEndOfPeriod 42M 39M 56M 55M 76M 78M 61M 58M 45M 30M 30M 29M 48M
cashAtBeginningOfPeriod 39M 56M 76M 76M 45M 61M 58M 45M 29M 30M 25M 48M 54M
operatingCashFlow 5M -16M -10M -18M -28M -13M 5M -26M 78 000 1M 7M -7M 24M
capitalExpenditure -422 000 -731 000 -4M -1M -6M -4M -554 000 -791 000 -4M -666 000 -1M -4M -5M
freeCashFlow 4M -17M -15M -19M -34M -16M 5M -27M -4M 704 000 6M -11M 19M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-07-18 2024-07-25 2023-08-03 2022-07-22 2021-07-27
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities -6M 126M -6M -11M -9M
netCashProvidedByInvestingActivities -10M 124M -10M -19M -14M
netDebtIssuance 6M -50M 25M 5M -20M
longTermNetDebtIssuance 6M -50M 25M 5M -20M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -2M 752 000 1M 3M 3M
netCommonStockIssuance -2M 752 000 1M 3M 3M
commonStockIssuance 0 752 000 1M 3M 3M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -5M -15M -751 000 0 0
netCashProvidedByFinancingActivities -255 000 -64M 25M 8M -17M
incomeTaxesPaid 800 000 455 000 342 000 329 000 313 000
interestPaid 185 000 0 3M 562 000 731 000

Earning call transcript

2025 q4
2026-01-06 ET (fiscal 2026 q2)
2025 q3
2025-10-02 ET (fiscal 2026 q1)
2025 q2
2025-07-15 ET (fiscal 2025 q4)
2025 q1
2025-04-02 ET (fiscal 2025 q3)
2024 q4
2025-01-08 ET (fiscal 2025 q2)
2024 q3
2024-10-03 ET (fiscal 2025 q1)
2024 q2
2024-07-16 ET (fiscal 2024 q4)
2024 q1
2024-04-04 ET (fiscal 2024 q3)
2023 q4
2024-01-05 ET (fiscal 2024 q2)
2023 q3
2023-10-04 ET (fiscal 2024 q1)
2023 q2
2023-07-12 ET (fiscal 2023 q4)
2023 q1
2023-03-30 ET (fiscal 2023 q3)
2022 q4
2023-01-05 ET (fiscal 2023 q2)
2022 q3
2022-10-06 ET (fiscal 2023 q1)
2022 q2
2022-07-12 ET (fiscal 2022 q4)
2022 q1
2022-04-07 ET (fiscal 2022 q3)
2021 q4
2022-01-06 ET (fiscal 2022 q2)
2021 q3
2021-09-30 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2026-01-06 15:19 ET
AngioDynamics reported for 2025 q4
SEC form 8
2026-01-06 07:15 ET
AngioDynamics published news for 2025 q4
SEC form 8
2026-01-06 07:15 ET
AngioDynamics reported for 2025 q4
SEC form 8
2026-01-06 07:15 ET
AngioDynamics published news for 2025 q4
SEC form 10
2025-10-02 20:07 ET
AngioDynamics published news for 2025 q3
SEC form 8
2025-10-02 11:30 ET
AngioDynamics published news for 2025 q3
SEC form 8
2025-10-02 11:30 ET
AngioDynamics reported for 2025 q3
SEC form 8
2025-10-02 11:30 ET
AngioDynamics published news for 2025 q3
SEC form 10
2025-07-18 14:38 ET
AngioDynamics reported for 2025 q2
SEC form 10
2025-07-18 00:00 ET
AngioDynamics reported for 2025 q2
SEC form 8
2025-07-15 11:16 ET
AngioDynamics published news for 2025 q2
SEC form 8
2025-07-15 11:16 ET
AngioDynamics reported for 2025 q2
SEC form 8
2025-07-15 11:16 ET
AngioDynamics published news for 2025 q2
SEC form 10
2025-04-02 14:14 ET
AngioDynamics reported for 2025 q1
SEC form 8
2025-04-02 13:40 ET
AngioDynamics published news for 2025 q1
SEC form 8
2025-04-02 13:40 ET
AngioDynamics published news for 2025 q1
SEC form 8
2025-04-02 07:23 ET
AngioDynamics published news for 2025 q1
SEC form 8
2025-04-02 07:23 ET
AngioDynamics reported for 2025 q1
SEC form 8
2025-04-02 07:23 ET
AngioDynamics published news for 2025 q1
SEC form 10
2025-04-02 00:00 ET
AngioDynamics reported for 2025 q1
SEC form 10
2025-01-08 14:07 ET
AngioDynamics reported for 2024 q4
SEC form 8
2025-01-08 07:00 ET
AngioDynamics reported for 2024 q4
SEC form 8
2025-01-08 07:00 ET
AngioDynamics published news for 2024 q4
SEC form 8
2025-01-08 07:00 ET
AngioDynamics published news for 2024 q4
SEC form 10
2025-01-08 00:00 ET
AngioDynamics reported for 2024 q4
SEC form 10
2024-10-03 17:08 ET
AngioDynamics published news for 2024 q3
SEC form 8
2024-10-03 07:30 ET
AngioDynamics published news for 2024 q3
SEC form 8
2024-10-03 07:30 ET
AngioDynamics published news for 2024 q3
SEC form 8
2024-10-03 07:30 ET
AngioDynamics reported for 2024 q3
SEC form 10
2024-10-03 00:00 ET
AngioDynamics published news for 2024 q3
SEC form 10
2024-07-25 00:00 ET
AngioDynamics reported for 2024 q2
SEC form 8
2024-07-16 07:22 ET
AngioDynamics published news for 2024 q2
SEC form 8
2024-07-16 07:22 ET
AngioDynamics reported for 2024 q2
SEC form 8
2024-07-16 07:22 ET
AngioDynamics published news for 2024 q2
SEC form 8
2024-07-16 07:15 ET
AngioDynamics published news for 2024 q2
SEC form 8
2024-07-16 07:15 ET
AngioDynamics published news for 2024 q2
SEC form 10
2024-04-09 00:00 ET
AngioDynamics reported for 2024 q1
SEC form 8
2024-04-04 07:30 ET
AngioDynamics published news for 2024 q1
SEC form 8
2024-04-04 07:30 ET
AngioDynamics reported for 2024 q1
SEC form 8
2024-04-04 07:30 ET
AngioDynamics published news for 2024 q1
SEC form 10
2024-01-08 00:00 ET
AngioDynamics reported for 2023 q4
SEC form 8
2024-01-05 07:15 ET
AngioDynamics reported for 2023 q4
SEC form 8
2024-01-05 07:15 ET
AngioDynamics published news for 2023 q4
SEC form 8
2024-01-05 07:15 ET
AngioDynamics published news for 2023 q4
SEC form 10
2023-10-05 17:15 ET
AngioDynamics reported for 2023 q3
SEC form 10
2023-10-05 00:00 ET
AngioDynamics reported for 2023 q3
SEC form 8
2023-10-04 07:15 ET
AngioDynamics reported for 2023 q3
SEC form 10
2023-08-03 00:00 ET
AngioDynamics reported for 2023 q2
SEC form 6
2023-07-12 07:30 ET
AngioDynamics reported for 2023 q2
SEC form 8
2023-07-12 00:00 ET
AngioDynamics reported for 2023 q2
SEC form 6
2023-06-14 16:39 ET
AngioDynamics published news for 2023 q1
SEC form 6
2023-06-08 17:05 ET
AngioDynamics published news for 2023 q1
SEC form 6
2023-06-02 15:36 ET
AngioDynamics published news for 2023 q1
SEC form 6
2023-06-02 07:00 ET
AngioDynamics published news for 2023 q1
SEC form 10
2023-03-31 00:00 ET
AngioDynamics reported for 2023 q1
SEC form 8
2023-03-30 00:00 ET
AngioDynamics published news for 2022 q4
SEC form 10
2023-01-06 00:00 ET
AngioDynamics reported for 2022 q4
SEC form 8
2023-01-05 00:00 ET
AngioDynamics reported for 2022 q4
SEC form 8
2022-11-30 00:00 ET
AngioDynamics published news for 2022 q3
SEC form 10
2022-10-11 00:00 ET
AngioDynamics reported for 2022 q3
SEC form 8
2022-10-06 00:00 ET
AngioDynamics reported for 2022 q3
SEC form 10
2022-07-22 00:00 ET
AngioDynamics reported for 2022 q2
SEC form 8
2022-07-12 00:00 ET
AngioDynamics reported for 2022 q2
SEC form 8
2022-04-07 00:00 ET
AngioDynamics reported for 2022 q1
SEC form 10
2022-04-07 00:00 ET
AngioDynamics reported for 2022 q1
SEC form 10
2022-01-07 00:00 ET
AngioDynamics published news for 2021 q4
SEC form 8
2022-01-06 00:00 ET
AngioDynamics published news for 2021 q4
SEC form 10
2021-09-30 00:00 ET
AngioDynamics published news for 2021 q3
SEC form 8
2021-09-30 00:00 ET
AngioDynamics published news for 2021 q2
SEC form 10
2021-07-27 00:00 ET
AngioDynamics published news for 2021 q2
SEC form 8
2021-07-13 00:00 ET
AngioDynamics published news for 2021 q2